Filter News
Area of Research
- (-) Supercomputing (19)
- Biological Systems (1)
- Biology and Environment (18)
- Clean Energy (44)
- Computational Biology (1)
- Electricity and Smart Grid (2)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (2)
- Fusion and Fission (24)
- Fusion Energy (4)
- Isotopes (7)
- Materials (28)
- Materials for Computing (3)
- National Security (33)
- Neutron Science (10)
- Nuclear Science and Technology (19)
News Topics
- (-) Biomedical (8)
- (-) Energy Storage (4)
- (-) Grid (2)
- (-) Mathematics (1)
- (-) National Security (4)
- (-) Nuclear Energy (2)
- 3-D Printing/Advanced Manufacturing (4)
- Artificial Intelligence (24)
- Big Data (14)
- Bioenergy (4)
- Biology (7)
- Biotechnology (1)
- Buildings (3)
- Chemical Sciences (2)
- Climate Change (13)
- Computer Science (52)
- Coronavirus (8)
- Cybersecurity (4)
- Decarbonization (4)
- Environment (14)
- Exascale Computing (14)
- Frontier (16)
- High-Performance Computing (26)
- Isotopes (1)
- Machine Learning (9)
- Materials (9)
- Materials Science (11)
- Microscopy (3)
- Molten Salt (1)
- Nanotechnology (7)
- Net Zero (1)
- Neutron Science (7)
- Physics (4)
- Quantum Computing (11)
- Quantum Science (11)
- Security (2)
- Simulation (12)
- Software (1)
- Space Exploration (2)
- Summit (22)
- Sustainable Energy (6)
- Transportation (4)
Media Contacts
Scientists at ORNL used their knowledge of complex ecosystem processes, energy systems, human dynamics, computational science and Earth-scale modeling to inform the nation’s latest National Climate Assessment, which draws attention to vulnerabilities and resilience opportunities in every region of the country.
Hilda Klasky, an R&D staff member in the Scalable Biomedical Modeling group at ORNL, has been selected as a senior member of the Association of Computing Machinery, or ACM.
The Exascale Small Modular Reactor effort, or ExaSMR, is a software stack developed over seven years under the Department of Energy’s Exascale Computing Project to produce the highest-resolution simulations of nuclear reactor systems to date. Now, ExaSMR has been nominated for a 2023 Gordon Bell Prize by the Association for Computing Machinery and is one of six finalists for the annual award, which honors outstanding achievements in high-performance computing from a variety of scientific domains.
Using disinformation to create political instability and battlefield confusion dates back millennia. However, today’s disinformation actors use social media to amplify disinformation that users knowingly or, more often, unknowingly perpetuate. Such disinformation spreads quickly, threatening public health and safety. Indeed, the COVID-19 pandemic and recent global elections have given the world a front-row seat to this form of modern warfare.
Researchers at the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.
ORNL researchers used the nation’s fastest supercomputer to map the molecular vibrations of an important but little-studied uranium compound produced during the nuclear fuel cycle for results that could lead to a cleaner, safer world.
A team of researchers has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.
To explore the inner workings of severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, researchers from ORNL developed a novel technique.
A world-leading researcher in solid electrolytes and sophisticated electron microscopy methods received Oak Ridge National Laboratory’s top science honor today for her work in developing new materials for batteries. The announcement was made during a livestreamed Director’s Awards event hosted by ORNL Director Thomas Zacharia.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.